Pseudohypoxia: Difference between revisions
CSV import Tag: Reverted |
No edit summary Tag: Manual revert |
||
| Line 19: | Line 19: | ||
{{disease-stub}} | {{disease-stub}} | ||
{{No image}} | {{No image}} | ||
Latest revision as of 17:17, 22 March 2025
Pseudohypoxia refers to increased cytosolic ratio of free NAD to NADH in cells, caused by hyperglycemia.<ref name=a>[1] Diabetes Magazine: Hyperglycemic Pseudohypoxia and Diabetic Complications, March 12, 1993</ref> Research has shown that declining levels of NAD+ during aging cause pseudohypoxia, and that raising nuclear NAD+ in old mice reverses pseudohypoxia and metabolic dysfunction, thus reversing the aging process.<ref>[2] Declining NAD+ Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication during Aging, Cell, Dec 2013</ref> It is expected that human NAD trials will begin in 2014.<ref>[3] Guardian Newspaper - Online, Dec 2013</ref>
Pseudohypoxia is a feature commonly noted in poorly-controlled diabetes.<ref name= a/>
See also[edit]
- Hypoxia (medical)
- Hypoxia (disambiguation) - list under Hypoxia (medical) e.g Intrauterine hypoxia
References[edit]
<references group="" responsive="1"></references>
